ANDRO
ANDRO, licence 80082924: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Trytan Health Inc. - Trytan Santé Inc.
- NPN or DIN-HM
- 80082924
- Status
- Active licence
- Licence date
- 7 February 2018
- Revision date
- 23 April 2021
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trigonella foenum-graecum Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 800 milligramme | 80.0 milligramme | Not calculated |
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 1500 milligramme | 375.0 milligramme | Not calculated |
| Lepidium meyenii Source : Hypocotyle Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 1500 milligramme | 375.0 milligramme | Not calculated |
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 750 milligramme | 15.0 milligramme | Not calculated |
| Panax ginseng Source : Radicelles Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 750 milligramme | 15.0 milligramme | Not calculated |
| Tribulus terrestris Source : Fruit | 15.0 milligramme | Not calculated |
| Chrome Source : Citrate de chrome(III) | 50.0 microgrammes | Not calculated |
Non-medicinal ingredients
Maltodextrine, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Helps to support emotional aspects of sexual health. Used in Herbal Medicine to help enhance physical capacity performance. Helps support cognitive function and/or reduce mental fatigue.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have hypotension, do not use this product. If you have a liver deficiency, do not use this product.
- Effets indésirables connus
Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. Hypersensitivity/allergy has been known to occur; in which case, discontinue use. Diuretic effect may occur.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking antidepressant medications. Consult a health care practitioner prior to use if you are taking blood thinners or digoxin. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you have high blood pressure. If you suffer from any psychological disorder and/or condition such as frequent anxiety or depression, consult a healthcare practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner. If case of qi or blood deficiency, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80082924
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.